Cancer Test Firm Guardant Health Posts Smaller Than Expected Q3 Loss, Lifts Annual Sales Outlook
Portfolio Pulse from Vandana Singh
Guardant Health Inc (NASDAQ:GH) reported Q3 revenue of $143 million, up 22% Y/Y, beating the consensus of $137.37 million. The company also posted a smaller than expected Q3 loss and raised its annual sales outlook. However, GH shares are down 5.70% at $26.16 on the last check Tuesday.
November 07, 2023 | 4:26 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Guardant Health reported better than expected Q3 results and raised its annual sales outlook. Despite this, its shares fell by 5.70%.
Guardant Health reported strong Q3 results and raised its annual sales outlook, which are positive indicators for the company's performance. However, the stock price fell by 5.70%, indicating that the market may have expected even better results or that there are other factors at play affecting the stock's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100